David Hyman

David Hyman, currently Chief Medical Officer at Eli Lilly and Company and Loxo@Lilly, has a significant background in the medical field. Prior to their current roles, David served as an Associate Member and Chief of Early Drug Development at Memorial Sloan Kettering Cancer Center. Additionally, David was an Associate Professor of Medicine at Weill Cornell Medicine and completed their medical residency at New York Presbyterian Hospital. David earned their MD from Joan & Sanford I. Weill Medical College of Cornell University and a BS in Biology from Brown University.